While blood clotting is important to prevent blood loss and for our immunity, coagulation also can cause health issues and even death. Currently, one in four people worldwide dies from diseases and ...

Blood-thinning medicines may protect a group of people with atrial fibrillation who have often faced an uncertain treatment ...

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an inherent risk of serious bleeding due to ...

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an inherent risk of serious bleeding due to ...

Anticoagulant therapy for ischaemic stroke aims to prevent recurrent ischaemic stroke and venous thromboembolism. Several large clinical trials have provided insight into the safety and efficacy of ...

Anticoagulation therapy is used to prevent clot formation. They do not lyse clots but they prevent new clots from forming. Since warfarin takes time to act, heparin and warfarin are usually started ...

The makers of novel anticoagulant (NOAC) drugs have done well. A neutral observer might think these drugs are the next penicillin. The ads are everywhere, no medium spared. Influential thought leaders ...

The global rise in anticoagulant use has increased the number of major bleeding events that warrant timely and effective pharmacologic reversal. Reversal strategies should be informed by the ...

Emergency and hospital medicine physicians often chose anticoagulants for acute pulmonary embolism (PE) based on institutional culture and past practices rather than clinical guidelines. Common ...

The image illustrate the combined action of two molecules cooperating to inhibit thrombin. The antidote dissociates the two molecules, preventing the cooperativity. The association and dissociation of ...